#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Acute graft versus host disease in intestine Hepatic cirrhosis Barth syndrome Angiosarcoma non-metastatic Thromboangiitis obliterans Juvenile idiopathic arthritis VEXAS syndrome Infantile apnoea Congenital aplastic anaemia Neurodermatitis Desmoid tumour Pulmonary tuberculosis Hormone-dependent prostate cancer Hypochromic anaemia Leiomyosarcoma recurrent More trials…

    Learn about Rare Diseases

    Cystic fibrosis – Diagnostics Primary immunodeficiency syndrome – Life with Disease Factor VIII deficiency – Basic Information Isodicentric chromosome 15 syndrome – Treatment Toxic epidermal necrolysis – Trials in Disease Splenic marginal zone lymphoma – Diagnostics Synovial sarcoma recurrent – Life with Disease Optic glioma – Basic Information Retinitis pigmentosa IgA nephropathy – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Vincristine Sulfate Cemdisiran ANX007 ZILUCOPLAN Mecasermin Rinfabate Ddcart‐Cd19 GSKVX000000070250 Brodalumab Imipenem Monohydrate Lolium Perenne GSKVX000000034794 Cagrilintide Gd2Il18Cart Cyclophosphamide Ibutamoren Mesilate Ambroxol Hydrochloride Acp-017 Peboctocogene Camaparvovec OSIMERTINIB MESYLATE Vgl101 More therapies…

    Learn about Your Condition

    Pneumonia chlamydial Viral myocarditis Rhabdoid tumour Chronic spontaneous urticaria End stage renal disease Chorioretinitis Hypoparathyroidism Leiomyosarcoma C3 glomerulopathy Thyroid cancer Cardiac failure Rectal cancer stage II Pterygium Trigeminal neuralgia Mitral valve prolapse More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Pulmonary tuberculosis

  • Study of bedaquiline, pretomanid, linezolid and moxifloxacin combination treatment for patients with multidrug-resistant tuberculosis in France

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Bedaquiline
    • Clofazimine
    • Linezolid
    France

  • Study evaluating blood biomarkers for diagnosis and monitoring treatment in patients with pulmonary tuberculosis using isoniazid, rifampicin, pyrazinamide, and ethambutol combination

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Pulmonary tuberculosis
    • Pneumonia bacterial
    Investigated Drugs:
    • Ethambutol Hydrochloride
    • Isoniazid
    • Pyrazinamide
    Spain

  • Study of cysteamine combined with standard tuberculosis treatment in adults with pulmonary tuberculosis

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Pulmonary tuberculosis
    Investigated Drugs:
    • Mercaptamine
    Italy

  • Study on the Safety and Effectiveness of CC-11050 and Metformin for Patients with Rifampin-Resistant Tuberculosis

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Pulmonary tuberculosis
    Investigated Drugs:
    • Metformin Hydrochloride
    Romania

  • Study on Gremubamab for Patients with Bronchiectasis and Chronic Pseudomonas Aeruginosa Infection

    Not recruiting

    2 1
    Investigated Diseases:
    • Pulmonary tuberculosis
    • Bronchiectasis
    Investigated Drugs:
    • Gremubamab
    Spain

  • Study on the Effectiveness and Safety of High-Dose Rifampicin, Moxifloxacin, and Linezolid for Patients with Pulmonary Tuberculosis

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Pulmonary tuberculosis
    Investigated Drugs:
    • Ethambutol Hydrochloride
    • Isoniazid
    • Pyrazinamide
    Spain

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!